Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPO
2651
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.17M | ﹤0.01% |
9,892
+9,655
| +4,074% | +$1.14M |
|
|
SLCA
2652
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.17M | ﹤0.01% |
95,236
-5,352
| -5% | -$58.3K |
|
|
TRST
2653
Trustco Bank Corp NY
TRST
$985M
| $1.17M | ﹤0.01% |
31,770
+10,508
| +49% | +$370K |
|
2654
Invesco Mortgage Capital
IVR
$760M
| $1.16M | ﹤0.01% |
29,006
+8,796
| +44% | +$332K |
|
2655
AngioDynamics
ANGO
$621M
| $1.16M | ﹤0.01% |
49,643
-16,233
| -25% | -$328K |
|
2656
Enanta Pharmaceuticals
ENTA
$372M
| $1.16M | ﹤0.01% |
23,537
-1,233
| -5% | -$61.5K |
|
2657
Upland Software
UPLD
$12.8M
| $1.16M | ﹤0.01% |
2,460
+153
| +7% | +$73.8K |
|
|
HSII
2658
DELISTED
Heidrick & Struggles
HSII
| $1.16M | ﹤0.01% |
32,387
+4,189
| +15% | +$142K |
|
2659
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$3.93B
| $1.15M | ﹤0.01% |
28,800
-4,700
| -14% | -$173K |
|
2660
AutoNation
AN
$7.19B
| $1.15M | ﹤0.01% |
12,299
+3,073
| +33% | +$246K |
|
2661
Celldex Therapeutics
CLDX
$2.96B
| $1.14M | ﹤0.01% |
55,299
+54,799
| +10,960% | +$1.26M |
|
2662
Arrow Financial
AROW
$669M
| $1.14M | ﹤0.01% |
37,381
+7,534
| +25% | +$222K |
|
2663
CorVel
CRVL
$3.1B
| $1.14M | ﹤0.01% |
33,246
+2,148
| +7% | +$74.8K |
|
2664
Artivion
AORT
$1.34B
| $1.13M | ﹤0.01% |
50,159
+4,142
| +9% | +$101K |
|
2665
Seres Therapeutics
MCRB
$49.1M
| $1.13M | ﹤0.01% |
2,751
+1,569
| +133% | +$722K |
|
2666
Personalis
PSNL
$1.43B
| $1.13M | ﹤0.01% |
46,064
+36,979
| +407% | +$1.27M |
|
|
EVRI
2667
DELISTED
Everi Holdings
EVRI
| $1.13M | ﹤0.01% |
80,061
+53,551
| +202% | +$762K |
|
2668
PUT
Shake Shack
SHAK
$2.6B
| $1.13M | ﹤0.01% |
10,000
-72,400
| -88% | -$8.29M |
|
2669
Donnelley Financial Solutions
DFIN
$1.19B
| $1.13M | ﹤0.01% |
40,482
-20,182
| -33% | -$467K |
|
2670
PUT
C.H. Robinson
CHRW
$17.3B
| $1.13M | ﹤0.01% |
11,800
-322,700
| -96% | -$30.1M |
|
|
WBA
2671
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $1.13M | ﹤0.01% |
20,500
-109,300
| -84% | -$5.4M |
|
2672
Andersons Inc
ANDE
$2.4B
| $1.12M | ﹤0.01% |
41,032
+6,882
| +20% | +$182K |
|
2673
Anika Therapeutics
ANIK
$276M
| $1.12M | ﹤0.01% |
27,537
+3,807
| +16% | +$144K |
|
2674
Barclays
BCS
$93.7B
| $1.12M | ﹤0.01% |
109,852
| – | – |
|
2675
PUT
Celanese
CE
$4.82B
| $1.12M | ﹤0.01% |
7,500
| – | – |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.